Award recordCONTRACT

ALEXION PHARMACEUTICALS INC

PIID VA26213F0218· VHA· 262-NETWORK CONTRACT OFFICE 22· 6505 · DRUGS AND BIOLOGICALS· FY2013· $117,884 net obligations· UEI DKCXLGANZAN3· CT

Description

PHARMACEUTICAL DRUGS: SOLIRIS- STANDING ORDER FOR SPECIFIC PATIENT.

First action · last action
2012-10-01 · 2013-01-30
Transactions
2
First transaction's obligation
$114,421
Base + all options value (sum of deltas)
$117,884
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5942X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$117,884$0Base award · 2012-10-01 · this action $114,421 · running total $114,421Modification P00001 · 2013-01-30 · this action $3,464 · running total $117,884
  • Base2012-10-01+$114,421= $114,421
  • Mod P000012013-01-30+$3,464= $117,884
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2012-10-01+$114,421$114,421PHARMACEUTICAL DRUGS: SOLIRIS- STANDING ORDER FOR SPECIFIC PATIENT.
Mod P00001· FUNDING ONLY ACTION2013-01-30+$3,464$117,884PHARMACEUTICAL DRUGS: SOLIRIS- STANDING ORDER FOR SPECIFIC PATIENT.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DKCXLGANZAN3)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24526N0739245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$104,650FY2026
36F79726D0143NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0055260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$1,255,805FY2026
36C26025F0093260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$626,866FY2025
36C26024F0096260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$522,487FY2024

Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26216J3405SANOFI VACCINES US INC.262-NETWORK CONTRACT OFFICE 22$209,679FY2016
VA26216P3483JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC.262-NETWORK CONTRACT OFFICE 22$14,960FY2016
VA26216E3967MCKESSON CORPORATION262-NETWORK CONTRACT OFFICE 22$20,913,958FY2016
VA26216P2987PETNET SOLUTIONS, INC.262-NETWORK CONTRACT OFFICE 22$58,136FY2016
VA26216E3446MCKESSON CORPORATION262-NETWORK CONTRACT OFFICE 22$11,612,703FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26213F0218_3600_V797P5942X_3600 · retrieved 2026-09-26.